Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Papillomavirus Infections × Injections × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 5 Prostatic Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Stomach Neoplasms 3 Leukemia, Myeloid, Acute 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Ovarian Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lung Neoplasms 2 Disease 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Cancer, Papillary 1 Thrombosis 1 Thrombocytopenia 1 Thoracic Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Pituitary Neoplasms 1 Pediatric Solid Tumor, Unspecified, Protocol Specific 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Pancreatic Cancer Metastatic 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 21 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14 Papillomavirus Vaccines 9 Vaccines 6 Blood Specimen Collection 3 Watchful Waiting 2 Vaccines, Synthetic 2 Light Coagulation 2 Hepatitis A Vaccines 2 Engerix-B 2 lime 1 halofantrine 1 Sodium Chloride 1 Radiotherapy, Intensity-Modulated 1 Pentetic Acid 1 Olive Oil 1 Observation 1 Measles-Mumps-Rubella Vaccine 1 Laser Therapy 1 Injections 1 Imiquimod 1 Human Papillomavirus DNA Tests 1 Fluorouracil 1 Diphtheria-Tetanus-acellular Pertussis Vaccines 1 DTPa-HBV-IPV combined vaccine 1 Colposcopy 1 Cisplatin 1 Circumcision, Male 1 Chorionic Villi Sampling 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04199689 2025-03-25

V503-049

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡